Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene

Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene International Journal of Legal Medicine https://doi.org/10.1007/s00414-018-1874-9 LETTER TO THE EDITOR Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene 1,2 1,2 3 4 1,2 Frank R. Wendt & August E. Woerner & Antti Sajantila & Rodrigo S. Moura-Neto & Bruce Budowle Received: 12 March 2018 /Accepted: 28 May 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2018 The Gaedigk et al. article BA perspective by PharmVar: Are as to reflect most recent submitted findings. Additionally, we the hundreds of CYP2D6 haplotypes predicted by Wendt and encourage PharmVar, its affiliates, and other pharmacogenomics colleagues real?^ describes shortcomings of the 2017 Wendt researchers to release full-gene information as it becomes avail- et al. article BFull-gene haplotypes refine CYP2D6 able, rather than only those sites relevant to the PharmVar no- metabolizer phenotype inferences^ [1]. To summarize, they menclature table(s) or the repository of knowledge for their re- discuss (1) the lack of submission of novel variants to www. spective gene(s) of interest. In doing so, the initiative described PharmVar.org; (2) inaccurate activity score reporting, namely by Gaedigk and colleagues will continue to thrive. for those haplotypes containing the 843T>G SNP; (3) use of The Wendt et al. paper was intended http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Legal Medicine Springer Journals

Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene

Loading next page...
 
/lp/springer_journal/exploring-the-1000-genomes-project-haplotype-reporting-for-the-cyp2d6-QZfwNuL1FG
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Medicine & Public Health; Forensic Medicine; Medical Law; Medicine/Public Health, general
ISSN
0937-9827
eISSN
1437-1596
D.O.I.
10.1007/s00414-018-1874-9
Publisher site
See Article on Publisher Site

Abstract

International Journal of Legal Medicine https://doi.org/10.1007/s00414-018-1874-9 LETTER TO THE EDITOR Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene 1,2 1,2 3 4 1,2 Frank R. Wendt & August E. Woerner & Antti Sajantila & Rodrigo S. Moura-Neto & Bruce Budowle Received: 12 March 2018 /Accepted: 28 May 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2018 The Gaedigk et al. article BA perspective by PharmVar: Are as to reflect most recent submitted findings. Additionally, we the hundreds of CYP2D6 haplotypes predicted by Wendt and encourage PharmVar, its affiliates, and other pharmacogenomics colleagues real?^ describes shortcomings of the 2017 Wendt researchers to release full-gene information as it becomes avail- et al. article BFull-gene haplotypes refine CYP2D6 able, rather than only those sites relevant to the PharmVar no- metabolizer phenotype inferences^ [1]. To summarize, they menclature table(s) or the repository of knowledge for their re- discuss (1) the lack of submission of novel variants to www. spective gene(s) of interest. In doing so, the initiative described PharmVar.org; (2) inaccurate activity score reporting, namely by Gaedigk and colleagues will continue to thrive. for those haplotypes containing the 843T>G SNP; (3) use of The Wendt et al. paper was intended

Journal

International Journal of Legal MedicineSpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off